{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:17:57Z","timestamp":1781158677146,"version":"3.54.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2006,3]]},"abstract":"<jats:p>\n            Patients with autonomic failure are disabled by orthostatic hypotension, which can be worsened by the nighttime pressure natriuresis induced by associated supine hypertension. Several pharmacological agents are available that effectively reduce nighttime hypertension, but none of them prevent pressure natriuresis. Because hypertension of autonomic failure can be driven by residual sympathetic tone, we hypothesized that clonidine would be effective in reducing blood pressure (BP) and nocturnal natriuresis. Therefore, we determined the effect of placebo, 0.1 mg clonidine, and 0.1-mg\/h nitroglycerin transdermal patch on supine BP, orthostatic hypotension, and pressure natriuresis in 23 patients with primary autonomic failure and supine hypertension. Medications were given at 8:00\n            <jats:sc>pm<\/jats:sc>\n            , and BP was recorded every 2 hours for 12 hours. The maximal decrease in BP was seen 6 to 8 hours after drug administration and was similar to clonidine and nitroglycerin (\u221229\u00b19 and \u221230\u00b110 mm Hg, respectively), as was the average fall in BP throughout the night. However, only clonidine effectively reduced nocturnal natriuresis (\u22120.09 mmol\/mg Cr; 95% CI, \u22120.13 to \u22120.04;\n            <jats:italic>P<\/jats:italic>\n            =0.004), but this was not associated with improvement in morning orthostatic hypotension because of a residual hypotensive effect. The decrease in BP induced by clonidine was modestly but significantly correlated with the magnitude of residual sympathetic tone determined in 10 subjects by the fall in BP induced by ganglionic blockade (\n            <jats:italic>r<\/jats:italic>\n            =0.66;\n            <jats:italic>P<\/jats:italic>\n            =0.043). These results are consistent with residual sympathetic tone contributing to supine hypertension in autonomic failure, which can be targeted with clonidine to decrease BP and nocturnal natriuresis.\n          <\/jats:p>","DOI":"10.1161\/01.hyp.0000199982.71858.11","type":"journal-article","created":{"date-parts":[[2006,1,4]],"date-time":"2006-01-04T02:23:42Z","timestamp":1136341422000},"page":"522-526","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":69,"title":["Clonidine for the Treatment of Supine Hypertension and Pressure Natriuresis in Autonomic Failure"],"prefix":"10.1161","volume":"47","author":[{"given":"Cyndya","family":"Shibao","sequence":"first","affiliation":[{"name":"From the Division of Clinical Pharmacology, Department of Medicine and Pharmacology and the Autonomic Dysfunction Center, Vanderbilt University School of Medicine, Nashville, Tenn."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Gamboa","sequence":"additional","affiliation":[{"name":"From the Division of Clinical Pharmacology, Department of Medicine and Pharmacology and the Autonomic Dysfunction Center, Vanderbilt University School of Medicine, Nashville, Tenn."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Abraham","sequence":"additional","affiliation":[{"name":"From the Division of Clinical Pharmacology, Department of Medicine and Pharmacology and the Autonomic Dysfunction Center, Vanderbilt University School of Medicine, Nashville, Tenn."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish R.","family":"Raj","sequence":"additional","affiliation":[{"name":"From the Division of Clinical Pharmacology, Department of Medicine and Pharmacology and the Autonomic Dysfunction Center, Vanderbilt University School of Medicine, Nashville, Tenn."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Diedrich","sequence":"additional","affiliation":[{"name":"From the Division of Clinical Pharmacology, Department of Medicine and Pharmacology and the Autonomic Dysfunction Center, Vanderbilt University School of Medicine, Nashville, Tenn."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Black","sequence":"additional","affiliation":[{"name":"From the Division of Clinical Pharmacology, Department of Medicine and Pharmacology and the Autonomic Dysfunction Center, Vanderbilt University School of Medicine, Nashville, Tenn."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Robertson","sequence":"additional","affiliation":[{"name":"From the Division of Clinical Pharmacology, Department of Medicine and Pharmacology and the Autonomic Dysfunction Center, Vanderbilt University School of Medicine, Nashville, Tenn."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Italo","family":"Biaggioni","sequence":"additional","affiliation":[{"name":"From the Division of Clinical Pharmacology, Department of Medicine and Pharmacology and the Autonomic Dysfunction Center, Vanderbilt University School of Medicine, Nashville, Tenn."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02291236"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8651(01)00005-4"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V10135"},{"key":"e_1_3_2_4_2","first-page":"306","volume":"14","year":"2004","unstructured":"Pathak A, Bourdet B, Montrastuc JL, Amar J, Senard JM. Should nocturnal systolic blood pressure be treated in patients with neurogenic orthostatic hypotension? A prospective survival study. Clin Auto Res. 2004; 14: 306(abstract).","journal-title":"Clin Auto Res"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05320-9"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.101.23.2710"},{"key":"e_1_3_2_7_2","unstructured":"Robertson D. Assessment of autonomic function. In: Baughman KL Green BM eds. Manual for House Officers. Baltimore: Williams and Wilkins; 1981."},{"key":"e_1_3_2_8_2","unstructured":"Mosqueda-Garcia R. Evaluation of the autonomic nervous system. In: Robertson D Biaggioni I eds. Disorders of the Autonomic Nervous System. London: Harwood Academic; 1995."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113298"},{"key":"e_1_3_2_10_2","first-page":"847","volume":"93","year":"1979","unstructured":"Workman RJ, Sussman CR, Burkitt DW, Liddle GW. Circulating levels of angiotensin I measured by radioimmunoassay in hypertensive subjects. J Lab Clin Med. 1979; 93: 847\u2013856.","journal-title":"J Lab Clin Med"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200309000-00017"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(90)90005-M"},{"key":"e_1_3_2_13_2","first-page":"580","volume":"76","year":"1993","unstructured":"Biaggioni I, Garcia F, Inagami T, Haile V. Hyporeninemic normoaldosteronism in severe autonomic failure. J Clin Endocrinol Metabol. 1993; 76: 580\u2013586.","journal-title":"J Clin Endocrinol Metabol"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2001.00516.x"},{"key":"e_1_3_2_15_2","first-page":"377","volume":"38","year":"1969","unstructured":"Bannister R, Ardill L, Fentem P. Assessment of various methods of treatment of idiopathic orthostatic hypotension. Quart J Med. 1969; 38: 377\u2013395.","journal-title":"Quart J Med"},{"key":"e_1_3_2_16_2","first-page":"S49","volume":"36","year":"1992","unstructured":"LaRochelle P. Renal tubular effects of calcium antagonists. Kidney Int Suppl. 1992; 36: S49\u2013S53.","journal-title":"Kidney Int Suppl"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.7.3.438"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0750609"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.0000199982.71858.11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T16:38:04Z","timestamp":1715531884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.0000199982.71858.11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["10.1161\/01.HYP.0000199982.71858.11"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.0000199982.71858.11","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"2005-10-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-11-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2006-01-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}